AN2 Therapeutics (ANTX.US) Shareholder Detail - Holdings History & Trades | Longbridge

GC

Geode Capital Management, LLC

BuySellPriceUnit: Shares

Holdings History

Date
Latest	1.05%	+411.26K	1.85%	697.81K	06/30/2026
Q2 2026	1.13%	+411.26K	1.92%	697.81K	06/30/2026
Q1 2026	0.12%	+34.67K	0.80%	286.55K	03/31/2026
Q4 2025	<0.01%	+2.52K	0.92%	251.88K	12/31/2025
Q3 2025	<0.01%	+0	0.91%	249.35K	09/30/2025
Q2 2025	0.07%	-4.57K	0.91%	249.35K	06/30/2025
Q1 2025	0.08%	+26.13K	0.84%	253.92K	03/31/2025
Q4 2024	0.02%	+7.63K	0.76%	227.80K	12/31/2024
Q3 2024	0.13%	+39.24K	0.74%	220.16K	09/30/2024
Q2 2024	<0.01%	+1.55K	0.61%	180.92K	06/30/2024
Q1 2024	<0.01%	+747.00	0.60%	179.37K	03/31/2024
Q4 2023	0.30%	+88.93K	0.60%	178.62K	12/31/2023
Q3 2023	0.06%	+36.73K	0.30%	89.69K	09/30/2023
Q2 2023	0.50%	-91.99K	0.24%	52.96K	06/30/2023
Q1 2023	0.11%	+21.86K	0.75%	144.95K	03/31/2023